ZVSA

ZyVersa Therapeutics

Delisted

ZVSA was delisted on the 16th of July, 2025.

6 hedge funds and large institutions have $181K invested in ZyVersa Therapeutics in 2023 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
6
Holders Change
-3
Holders Change %
-33.33%
% of All Funds
0.09%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
1
Reduced
Closed
8
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
AFM
1
Anson Funds Management
Texas
$145K +$145K +16,067 New
TSS
2
Two Sigma Securities
New York
$16.8K +$16.8K +1,867 New
Citadel Advisors
3
Citadel Advisors
Florida
$13.5K +$13.5K +1,499 New
TRCT
4
Tower Research Capital (TRC)
New York
$3.58K +$3.44K +382 +2,388%
UBS Group
5
UBS Group
Switzerland
$2.95K +$2.95K +327 New
Wells Fargo
6
Wells Fargo
California
$9 +$9 +1 New
Walleye Capital
7
Walleye Capital
New York
-$128K -2,802 Closed
Geode Capital Management
8
Geode Capital Management
Massachusetts
-$16.1K -352 Closed
CAC
9
Cowen and Company
New York
-$6.48K -143 Closed
Vanguard Group
10
Vanguard Group
Pennsylvania
-$2.23K -49 Closed
XT
11
XTX Topco
Cayman Islands
-$2.19K -48 Closed
Millennium Management
12
Millennium Management
New York
-$1.99K -43 Closed
Susquehanna International Group
13
Susquehanna International Group
Pennsylvania
-$1.77K -39 Closed
WAG
14
Winthrop Advisory Group
Massachusetts
-$1.73K -38 Closed
Bank of America
15
Bank of America
North Carolina
-$13